P2Y6受体:对于动脉样硬化症来说是一个有前途的治疗点
Lixia Li1, Liting Lai1, Dan Qiu1
1School of Pharmaceutical Science, Hengyang Medical School, University of South China, Hengyang, Hunan, 421001, China.
European journal of pharmacology
|March 17, 2025
概括
P2Y6受体在动脉样硬化的发展中起着关键作用. 用对抗剂准这种受体显示出通过调节炎症途径来治疗动脉样硬化症的治疗潜力.
科学领域:
- 心血管科学 心血管科学
- 分子生物学分子生物学
- 药理学 药理学是指药理学的学科.
背景情况:
- 动脉样硬化是全球死亡的主要原因,涉及脂质积累,炎症和内皮功能障碍.
- 由细胞外UDP激活的P2Y6受体已成为动脉样硬化的一个重要因素.
- 虽然它的治疗潜力得到了认可,但P2Y6受体参与的确切机制仍然不完全理解.
研究的目的:
- 审查P2Y6受体在动脉样硬化的发病过程中的作用.
- 阐明P2Y6受体在关键细胞类型中促进动脉样硬化的机制.
- 讨论P2Y6受体对抗剂在动脉样硬化治疗中的治疗潜力.
主要方法:
- 文献综述,重点关注过去十年的研究.
- 在巨细胞,内皮细胞和血管光滑肌细胞中分析P2Y6受体功能.
- 对P2Y6受体对抗剂的当前知识的综合.
主要成果:
- 通过其在巨细胞,内皮细胞和血管光滑肌细胞中的作用,P2Y6受体有助于动脉样硬化.
- 已经确定了P2Y6受体激活促进动脉样硬化的特定分子机制.
- 开发P2Y6受体对抗剂已经显示出有前途.
结论:
- P2Y6受体是动脉样硬化的关键调解者.
- 理解P2Y6受体机制为治疗策略提供了洞察力.
- P2Y6受体对抗剂代表了动脉样硬化治疗的有希望的途径.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.3K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.3K
Transducer Mechanism: G Protein–Coupled Receptors
1.8K
G Protein–Coupled Receptors (GPCRs) are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to various stimuli. GPCRs regulate critical physiological pathways and are excellent drug targets for treating diseases such as diabetes, cancer, obesity, depression, or Alzheimer's. Nearly 35% of approved drugs implement their therapeutic effects by selectively interacting with specific GPCRs.
GPCRs are also called heptahelical,...
GPCRs are also called heptahelical,...
1.8K
G Protein-coupled Receptors
11.0K
G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
11.0K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
441
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
441
Amplifying Signals via Second Messengers
6.6K
Many receptor binding ligands are hydrophilic; they do not cross the cell membrane but bind to cell-surface receptors. Thus, their message must be relayed by second messengers present in the cell cytoplasm. There are several second messenger pathways, each with its own way of relaying information. For example, the G protein-coupled receptors can activate both phosphoinositol and cyclic AMP (cAMP) second messenger pathways. The phosphoinositol pathway is active when the receptor induces...
6.6K
IP3/DAG Signaling Pathway
11.8K
Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and...
11.8K


